New Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant Platform and Forms Collaboration with Ginkgo Bioworks

SaponiQx is proud to partner with Ginkgo Bioworks, Inc. to develop the next generation of saponin adjuvants. Pairing SaponiQx’s unique expertise in saponins and Gingko Bioworks’ powerful Foundry technology will provide a platform for innovation, moving the vaccine and adjuvant fields forward.